Total Funding
54
33
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
288025
Suda is focused on oromucosal drug delivery technology to develop pharmaceuticals that improve the health and lifestyle of patients.
Stephen Carter: CEO
About the Company
Suda Ltd (ASX: SUD) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. The many potential benefits of administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue,
gums and palate), include ease of use, lower dosage, reduced side effects and faster response time.
